1 / 4

North American Preventive Inhaler Market Size, Share and Forecast 2019-2025

The North American preventive inhaler market was $3.5 billion in 2018 and is anticipated to grow at a substantial rate of 1.0% during the forecast period. The major factors that are contributing significantly to the market growth include rising air pollution, growing geriatric population, and high healthcare expenditure. The US and Canada are the major economies of North America. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of the inhaler market in the North America region. The increasing demand for inhaler due to increasing COPD and asthma patients in the US has endorsed the approval of cohesive reimbursement policies in the US, is further fueling the growth of the market. The US is the major market due to greater healthcare expenditure and a higher prevalence rate of respiratory diseases.

pooja99
Download Presentation

North American Preventive Inhaler Market Size, Share and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research North American Preventive Inhaler Market Size, Segmentation, Share, Forecast, Analysis, Industry Report to 2025 To learn more about North American Preventive Inhaler Market report request a free sample copy @ https://www.omrglobal.com/request-sample/north-american-preventive-inhaler-market ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

  2. The North American preventive inhaler market was $3.5 billion in 2018 and is anticipated to grow at a substantial rate of 1.0% during the forecast period. The major factors that are contributing significantly to the market growth include rising air pollution, growing geriatric population, and high healthcare expenditure. The US and Canada are the major economies of North America. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of the inhaler market in the North America region. The increasing demand for inhaler due to increasing COPD and asthma patients in the US has endorsed the approval of cohesive reimbursement policies in the US, is further fueling the growth of the market. The US is the major market due to greater healthcare expenditure and a higher prevalence rate of respiratory diseases. A full report of North American Preventive Inhaler Market is available at https://www.omrglobal.com/industry-reports/north-american-preventive-inhaler-market The North American preventive inhaler market is segmented on the basis of device type, application, and end- user. On the basis of device type, the market is sub-segmented into the metered dosed inhaler and dry powdered inhaler. The dry powder inhaler is estimated to have the largest market share in the North American preventive inhaler market due to providing an easy inhalation solution. Whereas, the market for metered dose inhaler is estimated to be the fastest-growing at a CAGR during the forecast period owing to innovations and collaborations by the companies for the development of metered dosed inhaler. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. To learn more about North American Preventive Inhaler Market report request a free sample copy @ https://www.omrglobal.com/request-sample/north-american-preventive-inhaler-market North American Preventive Inhaler Market Segmentation By Device Type • Metered Dose Inhaler

  3. • Dry Powder Inhaler By Application • Asthma • Chronic Obstructive Pulmonary Disease (COPD) By End-User • Homecare • Hospitals and Clinics Regional Analysis • US • Canada Company Profiles • 3M Co. • Acorda Therapeutics, Inc. • Adamis Pharmaceuticals Corp. • Adherium Ltd. • Aradigm Corp. • AstraZeneca PLC • Boehringer Ingelheim International GmbH • Drive Devilbiss Healthcare LLC • GlaxoSmithKline PLC • Koninklijke Philips N.V. For more customized data, request for report customization @ https://www.omrglobal.com/report- customization/north-american-preventive-inhaler-market About us: Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services.

  4. For More Information, Visit https://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related